204 related articles for article (PubMed ID: 3927722)
1. Combinations of antibiotics against Pseudomonas aeruginosa.
Baltch AL; Smith RP
Am J Med; 1985 Jul; 79(1A):8-16. PubMed ID: 3927722
[TBL] [Abstract][Full Text] [Related]
2. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
Giamarellou H
Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
[TBL] [Abstract][Full Text] [Related]
3. Routine susceptibility testing of four antibiotic combinations for improvement of laboratory guide to therapy of cystic fibrosis infections caused by Pseudomonas aeruginosa.
Weiss K; Lapointe JR
Antimicrob Agents Chemother; 1995 Nov; 39(11):2411-4. PubMed ID: 8585718
[TBL] [Abstract][Full Text] [Related]
4.
Goodlet KJ; Nicolau DP; Nailor MD
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923865
[TBL] [Abstract][Full Text] [Related]
5. Synergistic activity of astromicin and beta-lactam antibiotics against Pseudomonas aeruginosa in vitro and in vivo.
Kitaura K; Mineura K; Nakamizo N; Shiba K; Ohmori M; Saito A; Ueda Y
J Antibiot (Tokyo); 1984 Dec; 37(12):1681-6. PubMed ID: 6441792
[TBL] [Abstract][Full Text] [Related]
6. Studies of in vitro synergy between several beta-lactam and aminoglycoside antibiotics against endocarditis strains of Pseudomonas aeruginosa.
Reyes MP; Smith F; Lerner AM
J Infect; 1984 Mar; 8(2):110-7. PubMed ID: 6725964
[TBL] [Abstract][Full Text] [Related]
7. Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs.
Rusnak MG; Drake TA; Hackbarth CJ; Sande MA
J Infect Dis; 1984 Jun; 149(6):980-5. PubMed ID: 6429255
[TBL] [Abstract][Full Text] [Related]
8. Pseudomonas aeruginosa susceptibility in a university hospital: recognition and treatment.
Rotschafer JC; Shikuma LR
Drug Intell Clin Pharm; 1986; 20(7-8):575-81. PubMed ID: 3091346
[TBL] [Abstract][Full Text] [Related]
9. Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections.
Van Eldere J
J Antimicrob Chemother; 2003 Feb; 51(2):347-52. PubMed ID: 12562701
[TBL] [Abstract][Full Text] [Related]
10. Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa.
Mimoz O; Elhelali N; Léotard S; Jacolot A; Laurent F; Samii K; Petitjean O; Nordmann P
J Antimicrob Chemother; 1999 Jul; 44(1):91-7. PubMed ID: 10459815
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of beta-lactams in combination with other antimicrobial agents against resistant strains of Pseudomonas aeruginosa.
Song W; Woo HJ; Kim JS; Lee KM
Int J Antimicrob Agents; 2003 Jan; 21(1):8-12. PubMed ID: 12507832
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic synergy against biofilm-forming Pseudomonas aeruginosa.
Cernohorská L; Votava M
Folia Microbiol (Praha); 2008; 53(1):57-60. PubMed ID: 18481219
[TBL] [Abstract][Full Text] [Related]
13. [Combined in vitro effect of new betalactam antibiotics and aminoglycosides against Pseudomonas aeruginosa ].
Thabaut A; Durosoir JL; Meyran M
Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):549-54. PubMed ID: 6812006
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa isolates from different medical institutions.
Nitzan Y; Sharon R; Maayan M; Steuerman C
Isr J Med Sci; 1985 Oct; 21(10):798-803. PubMed ID: 3935600
[TBL] [Abstract][Full Text] [Related]
15. Use of in vitro critical inhibitory concentration, a novel approach to predict in vivo synergistic bactericidal effect of combined amikacin and piperacillin against Pseudomonas aeruginosa in a systemic rat infection model.
Chan E; Zhou S; Srikumar S; Duan W
Pharm Res; 2006 Apr; 23(4):729-41. PubMed ID: 16554956
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the activity of antibiotic combinations in vitro with clinical outcome and resistance emergence in serious infection by Pseudomonas aeruginosa in non-neutropenic patients.
Chandrasekar PH; Crane LR; Bailey EJ
J Antimicrob Chemother; 1987 Mar; 19(3):321-9. PubMed ID: 3106305
[TBL] [Abstract][Full Text] [Related]
17. Synergistic activity of aminoglycoside-beta-lactam combinations against Pseudomonas aeruginosa with an unusual aminoglycoside antibiogram.
Clark RB; Pakiz CB; Hostetter MK
Med Microbiol Immunol; 1990; 179(2):77-86. PubMed ID: 2113159
[TBL] [Abstract][Full Text] [Related]
18. [Comparative bactericidal activity of beta-lactam-aminoglycoside combinations against Pseudomonas aeruginosa].
Cluzel M; Chanal M; Sirot J; Cluzel R
Nouv Presse Med; 1982 Nov; 11(46):3400-4. PubMed ID: 6818523
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of Pseudomonas aeruginosa strains isolated from hospitalized children.
Patzer J; Walkiewicz R; Dzierzanowska D
J Antimicrob Chemother; 1986 Jul; 18(1):45-9. PubMed ID: 3093444
[TBL] [Abstract][Full Text] [Related]
20. Evaluating Mono- and Combination Therapy of Meropenem and Amikacin against Pseudomonas aeruginosa Bacteremia in the Hollow-Fiber Infection Model.
Avent ML; McCarthy KL; Sime FB; Naicker S; Heffernan AJ; Wallis SC; Paterson DL; Roberts JA
Microbiol Spectr; 2022 Jun; 10(3):e0052522. PubMed ID: 35442072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
